- Report
- April 2023
- 100 Pages
Latin America
From €4369EUR$4,750USD£3,697GBP
- Report
- August 2022
- 111 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- August 2022
- 115 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- August 2022
- 111 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- August 2022
- 111 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- June 2022
- 138 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- June 2022
- 130 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- January 2022
- 120 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- July 2021
- 115 Pages
Global
From €4369EUR$4,750USD£3,697GBP
- Report
- July 2022
- 73 Pages
Global
From €2253EUR$2,450USD£1,907GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3219EUR$3,500USD£2,724GBP
- Report
- January 2025
- 85 Pages
Egypt
From €3219EUR$3,500USD£2,724GBP
- Report
- January 2025
- 84 Pages
Vietnam
From €3219EUR$3,500USD£2,724GBP
- Report
- December 2024
- 82 Pages
India
From €3219EUR$3,500USD£2,724GBP
- Report
- December 2024
- 80 Pages
India
From €3219EUR$3,500USD£2,724GBP
- Report
- August 2024
- 82 Pages
Japan
From €3219EUR$3,500USD£2,724GBP
- Report
- May 2024
- 183 Pages
Global
From €4139EUR$4,500USD£3,502GBP
- Report
- May 2024
- 83 Pages
India
From €3219EUR$3,500USD£2,724GBP
- Report
- April 2024
- 184 Pages
Global
From €4139EUR$4,500USD£3,502GBP
- Report
- November 2023
- 178 Pages
Global
From €4139EUR$4,500USD£3,502GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more